Clinical trials
Completed Phase 2 Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
170 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 15 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 13 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 5 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 170 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 24 |
| University of Toronto | 7 |
| Duke University | 5 |
| Indiana University | 5 |
| National Center for Complementary and Integrative Health (NCCIH) | 4 |
| Novartis Pharmaceuticals | 4 |
| University of Minnesota | 4 |
| VA Office of Research and Development | 4 |
| Brigham and Women's Hospital | 3 |
| Neuroscience Trials Australia | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 170 |
| Heart Diseases | 49 |
| Vascular Diseases | 25 |
| Hypertension | 22 |
| Coronary Artery Disease | 15 |
| Atherosclerosis | 14 |
| Hyperlipidemias | 13 |
| Myocardial Ischemia | 13 |
| Coronary Disease | 11 |
| Inflammation | 11 |
Trials
Showing 1 to 25 of 170. Each trial links to its page on Pharma Observatory.
70 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.